American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARA | DGX | DVA | ELAN | CHE |
| Company | American Renal Associates | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Elanco Animal Health Inc | Chemed Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 11.48 | 127.25 | 127.60 | 13.42 | 604.08 |
| High | 11.52 | 127.34 | 128.57 | 13.74 | 605.51 |
| Low | 11.33 | 125.42 | 125.64 | 13.33 | 595.69 |
| Last | 11.52 | 125.91 | 126.11 | 13.57 | 597.42 |
| Change | +0.02 | -1.07 | -1.53 | +0.16 | -6.75 |
| % Change | +0.17% | -0.84% | -1.20% | +1.19% | -1.12% |
| Volume | 9,800 | 870,014 | 652,233 | 3,809,032 | 69,785 |
| 20-Day Average Volume | 110,105 | 840,003 | 488,312 | 3,645,118 | 58,035 |
| Previous Close | 11.50 | 126.98 | 127.64 | 13.41 | 604.17 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.47 | 130.19 | 133.28 | 15.18 | 628.32 |
| 20-Day Raw Stochastic | 100.00% | 3.84% | 6.78% | 8.49% | 4.20% |
| 20-Day Relative Strength | 70.89% | 41.82% | 43.25% | 30.94% | 36.09% |
| Weighted Alpha | -7.72 | -12.32 | +48.64 | +31.68 | +7.67 |
| Today's Opinion | 100% Buy | 72% Sell | 56% Buy | 24% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 64% Sell | 56% Buy | 24% Buy | 56% Buy |
| Last Month's Opinion | 72% Buy | 72% Sell | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 01/15/21 | -3.24% since 04/11/24 | -3.68% since 04/11/24 | -7.80% since 04/11/24 | -3.37% since 04/11/24 |
| Low | 11.33 on 01/25/21 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 13.33 on 04/18/24 | 595.69 on 04/18/24 |
| High | 11.52 on 01/25/21 | 130.30 on 04/12/24 | 133.08 on 04/15/24 | 14.74 on 04/12/24 | 625.09 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.70% since 12/24/20 | -1.82% since 03/18/24 | -7.63% since 03/18/24 | -13.81% since 03/18/24 | -7.88% since 03/18/24 |
| Low | 11.33 on 01/25/21 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 13.33 on 04/18/24 | 595.69 on 04/18/24 |
| High | 11.52 on 01/25/21 | 135.45 on 04/01/24 | 139.38 on 03/20/24 | 16.51 on 03/21/24 | 653.75 on 03/19/24 |
| 3-Month | |||||
| %Chg | +0.17% since 10/23/20 | -6.28% since 01/18/24 | +20.07% since 01/18/24 | -8.11% since 01/18/24 | +0.82% since 01/18/24 |
| Low | 11.33 on 01/25/21 | 123.04 on 02/01/24 | 103.40 on 01/23/24 | 13.33 on 04/18/24 | 569.07 on 02/13/24 |
| High | 11.52 on 01/25/21 | 135.45 on 04/01/24 | 141.54 on 03/13/24 | 16.88 on 02/26/24 | 654.62 on 03/15/24 |
| 6-Month | |||||
| %Chg | +80.56% since 07/24/20 | +2.46% since 10/18/23 | +60.74% since 10/18/23 | +42.56% since 10/18/23 | +15.33% since 10/18/23 |
| Low | 6.08 on 09/21/20 | 120.87 on 10/24/23 | 75.47 on 10/30/23 | 8.52 on 10/27/23 | 502.64 on 10/25/23 |
| High | 11.98 on 10/06/20 | 143.63 on 01/02/24 | 141.54 on 03/13/24 | 16.88 on 02/26/24 | 654.62 on 03/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 397,935 | 14,101,890 | 11,194,026 | 6,610,728 | 9,133,232 |
| Shares Outstanding, K | 34,543 | 111,056 | 87,700 | 492,970 | 15,117 |
| Annual Sales | 822,520,000 | 9,252,000,000 | 12,140,150,000 | 4,417,000,000 | 2,264,420,000 |
| Annual Net Income | -13,790,000 | 854,000,000 | 691,540,000 | -1,231,000,000 | 272,510,000 |
| Last Quarter Sales | 209,690,000 | 2,288,000,000 | 3,145,750,000 | 1,035,000,000 | 585,910,000 |
| Last Quarter Net Income | -2,690,000 | 192,000,000 | 150,670,000 | -141,000,000 | 90,050,000 |
| 60-Month Beta | 1.11 | 0.91 | 1.04 | 1.29 | 0.42 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.15 on 02/01/24 | 1.87 on 02/13/24 | 0.08 on 02/26/24 | 6.60 on 02/27/24 |
| Latest Earnings Date | 03/15/21 | 04/23/24 | 05/13/24 | 05/14/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.710 on 01/16/24 | N/A | N/A | 0.400 on 02/23/24 |
| Next Ex-Dividends Date | N/A | 01/16/24 | N/A | N/A | 02/23/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.63 | 15.49 | 15.33 | 29.02 |